srch

09.09.2021 · BOSTON,MA / ACCESSWIRE / September 9,2021 / Pieris Pharmaceuticals, Inc. (NASDAQ:PIRS), a clinical-stage biotechnology company advancing novel biotherapeutics through its proprietary Anticalin ...

Boston Pharmaceuticals Investors. Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info; This information is available in the PitchBook Platform. To explore Boston Pharmaceuticals‘s full profile, request access. Request a free trial. Boston Pharmaceuticals Investments (2) Company Name Deal Date

8:00am EDT. Boston Scientific Conference Call Discussing Third Quarter Financial Results ... 8:30am EDT. Boston Scientific 2021 Investor Day.

15.11.2021 · The Investor Relations website contains information about Rhythm Pharmaceuticals, Inc.'s business for stockholders, potential investors, and financial analysts.

Boston Pharmaceuticals is a portfolio company of Waypoint Capital, an investment firm based in Europe and focused on healthcare, ...

12-19-19 - Boston Pharmaceuticals Appoints Joanne Beck, PhD, as Chief Operating ... Boston Pharmaceuticals to Present at 2018 BIO CEO & Investor Conference ...

Boston Pharmaceuticals to Present at 2018 BIO CEO & Investor. Conference. CAMBRIDGE, Mass. – February 6, 2018 - Boston Pharmaceuticals (the “Company”) today.

Boston Pharmaceuticals acquires and transforms innovative molecules into differentiated medicines that improve patients’ lives. We have rapidly built a portfolio of high-value candidates across multiple therapeutic areas and are actively seeking additional programs for our diverse pipeline.

Investor Relations. Fusion Pharmaceuticals is a clinical-stage biopharmaceutical company developing next-generation ... Boston, MA 02110 (617) 420-5698.

26.04.2021 · Boston Pharmaceuticals is a portfolio company of Waypoint Capital, an investment firm based in Europe and focused on healthcare, medical technologies, and asset management. For more information, please visit www.bostonpharmaceuticals.com or follow us on Twitter @BosPharma and LinkedIn.

Dec 27, 2021 · BOSTON, MA / ACCESSWIRE / December 27, 2021 / Block & Leviton announces that a class action lawsuit has been filed against Reata Pharmaceuticals, Inc. (NASDAQ: RETA) for potential securities law ...

A new company, Boston Pharmaceuticals, has been created by Gurnet Point Capital, the investment firm formed earlier this year by Swiss ...

Apr 26, 2021 · Boston Pharmaceuticals is a portfolio company of Waypoint Capital, an investment firm based in Europe and focused on healthcare, medical technologies, and asset management. For more information, please visit www.bostonpharmaceuticals.com or follow us on Twitter @BosPharma and LinkedIn. Forward-Looking Statements:

Information on valuation, funding, acquisitions, investors, and executives for Boston Pharmaceuticals. Use the PitchBook Platform to explore the full profile.

2/6/2018. Boston Pharmaceuticals to Present at 2018 BIO CEO & Investor Conference. 1/4/2018. Pierre Fabre Enters Worldwide Licensing Agreement with Boston Pharmaceuticals for a Selective Potassium Channel Blocker for Atrial Fibrillation. 1/3/2018. Boston Pharmaceuticals Appoints Dr. Peter Ho as Chief Medical Officer.

27.12.2021 · BOSTON, MA / ACCESSWIRE / December 27, 2021 / Block & Leviton announces that a class action lawsuit has been filed against Reata Pharmaceuticals, Inc. (NASDAQ: RETA) for potential securities law ...

November 19, 2015: Gurnet Point Capital, an investment firm focused on the ... Boston Pharmaceuticals is agnostic to therapeutic area specialization, ...

Sep 09, 2021 · BOSTON,MA / ACCESSWIRE / September 9,2021 / Pieris Pharmaceuticals, Inc. (NASDAQ:PIRS), a clinical-stage biotechnology company advancing novel biotherapeutics through its proprietary Anticalin ...

Information on valuation, funding, acquisitions, investors, and executives for Boston Pharmaceuticals. Use the PitchBook Platform to explore the full ...

Boston Pharmaceuticals acquires and transforms innovative molecules into differentiated medicines that improve patients’ lives. We have rapidly built a portfolio of high-value candidates across multiple therapeutic areas and are actively seeking additional programs for …

28.07.2021 · BOSTON, MA / ACCESSWIRE / July 28, 2021 / Pieris Pharmaceuticals, Inc. (NASDAQ:PIRS), a clinical-stage biotechnology company advancing novel biotherapeutics through its proprietary Anticalin ...

Nov 15, 2021 · Boston, MA 02116. CUSIP number. 76243J105. Transfer Agent. Computershare Trust Company, Inc. 250 Royall Street Canton, MA 02021 www.computershare.com US Phone: +1-800-962-4284 International Phone: + 1-781-575-3120

11.11.2021 · HOLBAEK, Denmark, Nov. 11, 2021 /PRNewswire/ -- Pharmacosmos Group, a leader in the development of innovative treatments for patients suffering from iron deficiency and iron deficiency anemia, today announced the acquisition of AbFero Pharmaceuticals, Inc., a Boston based, privately-held clinical stage pharmaceutical company dedicated to treating diseases of …